A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]
Invivyd (NASDAQ:IVVD) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Invivyd (NASDAQ:IVVD) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
Invivyd (NASDAQ:IVVD) had its "hold" rating reaffirmed by analysts at D. Boral Capital.
Invivyd to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]